Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Brain Res

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    July 2018
  1. MAMAIS A, Manzoni C, Nazish I, Arber C, et al
    Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology.
    Brain Res. 2018 Jul 25. pii: S0006-8993(18)30407.
    PubMed     Text format     Abstract available


    May 2018
  2. LEI J, Conradi N, Abel C, Frisch S, et al
    Cognitive effects of rhythmic auditory stimulation in Parkinson's disease: A P300 study.
    Brain Res. 2018 May 16. pii: S0006-8993(18)30262.
    PubMed     Text format     Abstract available


    March 2018
  3. MARSHALL C, King KM, Kortagere S
    Limitations of the rat medial forebrain lesion model to study prefrontal cortex mediated cognitive tasks in Parkinson's Disease.
    Brain Res. 2018 Mar 30. pii: S0006-8993(18)30178.
    PubMed     Text format     Abstract available


  4. KLAVER AC, Coffey MP, Aasly JO, Loeffler DA, et al
    CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutations.
    Brain Res. 2018;1683:12-16.
    PubMed     Text format     Abstract available


    February 2018
  5. YANG X, Zhu Z, Ding X, Wang X, et al
    CaMKII inhibition ameliorated levodopa-induced dyskinesia by downregulating tyrosine hydroxylase activity in an experimental model of Parkinson's disease.
    Brain Res. 2018 Feb 14. pii: S0006-8993(18)30071.
    PubMed     Text format     Abstract available


    January 2018
  6. LIDDLE RA
    Parkinson's Disease from the Gut.
    Brain Res. 2018 Jan 19. pii: S0006-8993(18)30018.
    PubMed     Text format     Abstract available


    December 2017
  7. KELM-NELSON CA, Brauer AFL, Barth KJ, Lake JM, et al
    Characterization of early-onset motor deficits in the Pink1 -/- mouse model of Parkinson disease.
    Brain Res. 2017 Dec 8. pii: S0006-8993(17)30536.
    PubMed     Text format     Abstract available


    November 2017
  8. LIN D, Liang Y, Jing X, Chen Y, et al
    Microarray analysis of an synthetic alpha-synuclein induced cellular model reveals the expression profile of long non-coding RNA in Parkinson's disease.
    Brain Res. 2017 Nov 11. pii: S0006-8993(17)30502.
    PubMed     Text format     Abstract available


    October 2017
  9. ZHANG R, Andersen AH, Hardy PA, Forman E, et al
    Objectively measuring effects of electro-acupuncture in parkinsonian rhesus monkeys.
    Brain Res. 2017 Oct 7. pii: S0006-8993(17)30446.
    PubMed     Text format     Abstract available


    September 2017
  10. WILLIS GL, Freelance CB
    A Historical Review on the Emerging Preclinical Interest Concerning the Role of Circadian Function in Parkinson's disease.
    Brain Res. 2017 Sep 25. pii: S0006-8993(17)30424.
    PubMed     Text format     Abstract available


    July 2017
  11. LI M, Li L, Wang K, Su W, et al
    The effect of electroacupuncture on proteomic changes in the motor cortex of 6-OHDA Parkinsonian rats.
    Brain Res. 2017 Jul 28. pii: S0006-8993(17)30326.
    PubMed     Text format     Abstract available


    May 2017
  12. HOPFNER F, Kunstner A, Muller SH, Kunzel S, et al
    Gut Microbiota in Parkinson Disease in a northern German cohort.
    Brain Res. 2017 May 12. pii: S0006-8993(17)30180.
    PubMed     Text format     Abstract available


    March 2017
  13. CAUQUIL AS, Ory-Magne F, Jardine V, Galitzky M, et al
    Parkinson's patients can rely on perspective cues to perceive 3D space.
    Brain Res. 2017 Mar 18. pii: S0006-8993(17)30125.
    PubMed     Text format     Abstract available


  14. LEE Y, Heo G, Lee KM, Kim AH, et al
    Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
    Brain Res. 2017 Mar 17. pii: S0006-8993(17)30133.
    PubMed     Text format     Abstract available


    February 2017
  15. BALUCHNEJADMOJARAD T, Rabiee N, Zabihnejad S, Roghani M, et al
    Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERbeta/Nrf2/HO-1 signaling.
    Brain Res. 2017 Feb 23. pii: S0006-8993(17)30092.
    PubMed     Text format     Abstract available


    December 2016
  16. QUINTERO-ESPINOSA D, Jimenez-Del-Rio M, Velez-Pardo C
    Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson's disease.
    Brain Res. 2016 Dec 29. pii: S0006-8993(16)30844.
    PubMed     Text format     Abstract available


  17. FALQUETTO B, Tuppy M, Potje SR, Moreira TS, et al
    Cardiovascular dysfunction associated with neurodegeneration in an experimental model of parkinson's disease.
    Brain Res. 2016 Dec 9. pii: S0006-8993(16)30819.
    PubMed     Text format     Abstract available


    November 2016
  18. ZHANG ZN, Zhang JS, Xiang J, Yu ZH, et al
    Subcutaneous rotenone rat model of Parkinson's disease: dose exploration study.
    Brain Res. 2016 Nov 19. pii: S0006-8993(16)30776.
    PubMed     Text format     Abstract available


  19. DENG Q, Zhou X, Chen J, Pan M, et al
    Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.
    Brain Res. 2016 Nov 10. pii: S0006-8993(16)30744.
    PubMed     Text format     Abstract available


  20. JANG Y, Koo JH, Kwon I, Kang EB, et al
    Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice.
    Brain Res. 2016 Nov 3. pii: S0006-8993(16)30740.
    PubMed     Text format     Abstract available


    September 2016
  21. FARRAND AQ, Gregory RA, Backman CM, Helke KL, et al
    Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.
    Brain Res. 2016 Sep 19. pii: S0006-8993(16)30653.
    PubMed     Text format     Abstract available


  22. LIU KC, Li JY, Xie W, Li LB, et al
    Activation and blockade of serotonin6 receptors in the dorsal hippocampus enhance T maze and hole-board performance in a unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Brain Res. 2016 Sep 8. pii: S0006-8993(16)30617.
    PubMed     Text format     Abstract available


    August 2016
  23. LEMOS J, Pereira D, Almendra L, Rebelo D, et al
    Distinct functional properties of the vertical and horizontal saccadic network in Health and Parkinson's Disease: an eye-tracking and fMRI study.
    Brain Res. 2016 Aug 18. pii: S0006-8993(16)30520.
    PubMed     Text format     Abstract available


  24. TAMAS G, Kelemen A, Radics P, Valalik I, et al
    Effect of subthalamic stimulation on distal and proximal upper limb movements in Parkinson's disease.
    Brain Res. 2016 Aug 16. pii: S0006-8993(16)30556.
    PubMed     Text format     Abstract available


    July 2016
  25. MORO C, Massri NE, Darlot F, Torres N, et al
    Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease.
    Brain Res. 2016 Jul 7. pii: S0006-8993(16)30478.
    PubMed     Text format     Abstract available


    June 2016
  26. JIAO J, Guo H, He Y, Wang J, et al
    Meta-analysis of the association between serum iron levels and Parkinson's disease: Evidence from 11 publications.
    Brain Res. 2016 Jun 29. pii: S0006-8993(16)30467.
    PubMed     Text format     Abstract available


  27. MOLLAEI F, Shiller DM, Baum SR, Gracco VL, et al
    Sensorimotor control of vocal pitch and formant frequencies in Parkinson's disease.
    Brain Res. 2016 Jun 8. pii: S0006-8993(16)30437.
    PubMed     Text format     Abstract available


    May 2016
  28. HANSEN HH, Fabricius K, Barkholt P, Mikkelsen JD, et al
    Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Brain Res. 2016 May 24. pii: S0006-8993(16)30400.
    PubMed     Text format     Abstract available


  29. SU C, Yang X, Lou J
    Geniposide reduces alpha-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
    Brain Res. 2016 May 9. pii: S0006-8993(16)30366.
    PubMed     Text format     Abstract available


    April 2016
  30. MERCADO G, Castillo V, Soto P, Sidhu A, et al
    ER stress and Parkinson disease: Pathological inputs that converge into the secretory pathway.
    Brain Res. 2016 Apr 18. pii: S0006-8993(16)30260.
    PubMed     Text format     Abstract available


    December 2015
  31. CARRIERE CH, Kang NH, Niles LP
    CHRONIC LOW-DOSE MELATONIN TREATMENT MAINTAINS NIGROSTRIATAL INTEGRITY IN AN INTRASTRIATAL ROTENONE MODEL OF PARKINSON'S DISEASE.
    Brain Res. 2015 Dec 28. pii: S0006-8993(15)00975.
    PubMed     Text format     Abstract available


  32. ZHANG Z, Hou L, Li X, Ju C, et al
    Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and alpha-synuclein aggregation in 6-OHDA induced parkinson's disease cell model.
    Brain Res. 2015 Dec 28. pii: S0006-8993(15)00974.
    PubMed     Text format     Abstract available


    November 2015
  33. LEDREUX A, Boger HA, Hinson VK, Cantwell K, et al
    BDNF LEVELS ARE INCREASED BY AMINOINDAN AND RASAGILINE IN A DOUBLE LESION MODEL OF PARKINSON'S DISEASE.
    Brain Res. 2015 Nov 19. pii: S0006-8993(15)00872.
    PubMed     Text format     Abstract available


  34. MAHONEY JR, Holtzer R, Izzetoglu M, Zemon V, et al
    The role of prefrontal cortex during postural control in Parkinsonian syndromes a functional near-infrared spectroscopy study.
    Brain Res. 2015 Nov 6. pii: S0006-8993(15)00840.
    PubMed     Text format     Abstract available


    October 2015
  35. JI C, Xue GF, Lijun C, Feng P, et al
    A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
    Brain Res. 2015 Oct 9. pii: S0006-8993(15)00733.
    PubMed     Text format     Abstract available


  36. LEE Y, Jeong Chun H, Moon Lee K, Jung YS, et al
    Silibinin Suppresses Astroglial Activation in a Mouse Model of Acute Parkinson's Disease by Modulating the ERK and JNK Signaling Pathways.
    Brain Res. 2015 Oct 1. pii: S0006-8993(15)00727.
    PubMed     Text format     Abstract available


    September 2015
  37. SHETTY AK, Bates A
    Potential of GABA-ergic Cell Therapy for Schizophrenia, Neuropathic Pain, and Alzheimer's and Parkinson's Diseases.
    Brain Res. 2015 Sep 27. pii: S0006-8993(15)00717.
    PubMed     Text format     Abstract available


  38. LIU B, Sun J, Zhang J, Mao W, et al
    Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson's disease.
    Brain Res. 2015 Sep 2. pii: S0006-8993(15)00676.
    PubMed     Text format     Abstract available


  39. YAO N, Wu Y, Zhou Y, Ju L, et al
    Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson's disease.
    Brain Res. 2015 Sep 2. pii: S0006-8993(15)00675.
    PubMed     Text format     Abstract available


    August 2015
  40. DOTY KR, Guillot-Sestier MV, Town T
    The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Brain Res. 2015;1617:155-73.
    PubMed     Text format     Abstract available


  41. TOLLESON CM, Dobolyi D, Roman OC, Kanoff K, et al
    Dysrhythmia of timed Movements in Parkinson's disease and freezing of gait.
    Brain Res. 2015 Aug 1. pii: S0006-8993(15)00585.
    PubMed     Text format     Abstract available


    July 2015
  42. WENKER SD, Celeste Leal M, Isabel Farias M, Zeng X, et al
    Cell therapy for Parkinson s disease: Functional role of the Host immune response on survival and differentiation of dopaminergic neuroblasts.
    Brain Res. 2015 Jul 31. pii: S0006-8993(15)00589.
    PubMed     Text format     Abstract available


  43. ZHOU JJ, Zhai SY, Zhang HN, Wang YH, et al
    Neuroprotective effects of 3-O-demethylswertipunicoside against MPTP-induced Parkinsons disease in vivo and its antioxidant properties in vitro.
    Brain Res. 2015 Jul 23. pii: S0006-8993(15)00548.
    PubMed     Text format     Abstract available


    June 2015
  44. LAZZARA CA, Riley RR, Rane A, Andersen JK, et al
    The combination of lithium and L-dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson's disease therapy.
    Brain Res. 2015 Jun 25. pii: S0006-8993(15)00489.
    PubMed     Text format     Abstract available


  45. SHAN L, Diaz O, Zhang Y, Ladenheim B, et al
    L-Dopa induced dyskinesias in Parkinsonian mice: disease severity or L-Dopa history.
    Brain Res. 2015 Jun 15. pii: S0006-8993(15)00475.
    PubMed     Text format     Abstract available


  46. BARRETT PJ, Timothy Greenamyre J
    Post-translational modification of alpha-synuclein in Parkinson's disease.
    Brain Res. 2015 Jun 12. pii: S0006-8993(15)00471.
    PubMed     Text format     Abstract available


  47. BRIGGS CE, Wang Y, Kong B, Woo TU, et al
    Midbrain dopamine neurons in Parkinsons disease exhibit a dysregulated miRNA and target-gene network.
    Brain Res. 2015 Jun 3. pii: S0006-8993(15)00423.
    PubMed     Text format     Abstract available


    April 2015
  48. LIU FT, Chen Y, Yang YJ, Yang L, et al
    Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant alpha-synuclein.
    Brain Res. 2015;1604:52-61.
    PubMed     Text format     Abstract available


    January 2015
  49. SONG L, Cortopassi G
    Mitochondrial complex I defects increase ubiquitin in substantia nigra.
    Brain Res. 2015;1594:82-91.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: